Results 211 to 220 of about 382,034 (365)

Engineered B7‐H3 Binding in Modular Gp2 Miniproteins

Biotechnology and Bioengineering, EarlyView.
ABSTRACT B7‐H3, an important immune checkpoint modulator of T‐cell function, is a tumor vasculature biomarker and is overexpressed in a variety of cancers. Its expression is associated with tumor growth, metastasis, and poor clinical prognosis, which makes B7‐H3 an appealing target for diagnostics and therapeutics.
Abbigael Harthorn, Hannah K. Windsor, Zachary Schmitz, Nathaniel Cheung, Ebube Agwaramgbo, Benjamin J. Hackel   +5 more
wiley   +1 more source

Need for specialized neuro-oncology units in low- and middle-income countries: Lessons learned from the COVID-19 pandemic

Glioma, 2021
Jhoan Sebastián Robledo-Arias, Veronica Arango-Machado, Michael Gregorio Ortega-Sierra, Ivan David Lozada-Martinez   +3 more
doaj   +1 more source

Decreasing glioma recurrence through adjuvant cancer stem cell inhibition

, 2010
Josh Neman, Rahul JandialDivision of Neurosurgery, City of Hope National Cancer Center, Duarte, CA, USAAbstract: Gliomas remain one of the most challenging solid organ tumors to treat and are marked clinically by invariable recurrence despite multimodal ...
Rahul Jandial, Josh Neman
core  

Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment

BMEMat, EarlyView.
Schematic presentation of CAP‐mediated TME remodeling. This review summarizes recent efforts in cold atmospheric plasma (CAP) application in cancer treatment, highlighting the anticancer potential of CAP, molecular mechanisms, and future perspectives for further improvement and clinical translation.
Israr Khan, Qiujie Fang, Cao Fei, Ziyuan Wang, Zhaowei Chen, Guojun Chen, Zhiming Xu, Shu Xu, Zhitong Chen   +8 more
wiley   +1 more source

Lipid metabolism as a marker for glioma aggressiveness. [PDF]

Biosci Rep
Ribas HT, Ribas GT, Paixão de Santana-Filho A, Jungles AG, Mesaros C, Guizelini D, Martinez GR, Trombetta-Lima M, Sassaki GL, Winnischofer SMB.   +9 more
europepmc   +1 more source

Nanomaterials‐mediated glycolysis rewriting to potentiate tumor immunotherapy

BMEMat, EarlyView.
This review systematically summarizes cutting‐edge advances in glycolysis‐rewiring nanomedicines, emphasizing their mechanisms in reversing immunosuppression and reinvigorating antitumor immune responses. Challenges in clinical translation and future directions for designing multifunctional metabolic‐immune modulators are also critically discussed ...
Zilin Ma, Songyan Li, Jie Yan, Xuechun Wang, Wen Zhao, Yunxuan Song, Dongdong Liu, Jianwei Jiao, Xiuying Duan, Guiqiang Zhang   +9 more
wiley   +1 more source

Single-cell transcriptomic profiling uncovers key molecular signatures in glioma pathogenesis. [PDF]

Front Genet
Gu C, Wu X, Yang L.
europepmc   +1 more source

The epidemiology of glioma in adults: a "state of the science" review.

Neuro-Oncology, 2014
Q. Ostrom, L. Bauchet, F. Davis, I. Deltour, James L. Fisher, C. E. Langer, M. Pekmezci, J. Schwartzbaum, Michelle C. Turner, K. Walsh, M. Wrensch, J. Barnholtz-Sloan   +11 more
semanticscholar   +1 more source

Nanomaterial‐based immune therapeutic strategies in neurodegenerative diseases

BMEMat, EarlyView.
This review highlights the immunomodulatory potential of nanomaterials (NMs) in treating neurodegenerative diseases (NDs). It focuses on their roles in regulating innate and adaptive immune responses to maintain immune homeostasis. By providing insights into these mechanisms, the review lays the groundwork for innovative NMs therapeutic strategies to ...
Xinru Zhou, Jia Liu, Shulin Lai, Suhan Yin, Bingmin Luo, Longquan Shao, Yiyuan Kang   +6 more
wiley   +1 more source

The glioma neuron symbiosis hypothesis-cellular and molecular mechanistic considerations. [PDF]

Front Neurosci
Schurr A.
europepmc   +1 more source